Pharmaceutical And Laboratory Peristaltic Pumps

The Verderflex® Vantage 3000 range of tube pumps offer highly accurate, repeatable dosing, for low to medium flow. They are ideally suited for pharmaceutical and laboratory applications.

by Paul Dale | Thursday 13 June 2013

Verder_Vantage_3000.jpg
This simple to use, compact pump, may easily be used on a benchtop and is ideal for the transfer, dosing or metering of abrasive, shear sensitive and highly viscous fluids.

The Vantage 3000 operates at pressures of 2 Bar and is available to the end user in three drive options:

B Model - standard on/off, left/right function
C Model - remotely controlled analogue operation
P Model - dispensing, programmable & remote operation

A key feature of the Vantage 3000 is the easy tube load head, which can be changed in just three very easy, simple steps without any tools in seconds, therefore reducing downtime. Additional pump heads can be simply fitted to the pump, for simultaneous multiple dosing from a single pump.

Peristaltic tube pumps contain the liquid in the tube, eliminating the risk of contamination. This makes a peristaltic pump the perfect choice for aseptic applications where hygiene and sterility are critical to the process.

Additionally, a favourite feature is the Verderflex® Vantage 3000 ‘s programmable timed dosing option. This reliably dispenses a preset liquid volume, offering accurate and repeatable dosing up to ± 0.5%, with no product slip, providing piece of mind dosing and dramatically speeding up this process.

The Verderflex® Vantage 3000 peristaltic pump has proven remote control capabilities, with inputs for both a Remote stop/start and a 4 to 20 mA speed control it is easily integrated into a manufacturer’s equipment.

Subject to material compatibility, the Verderflex Vantage 3000’s tubing is certified to FDA CFR 21, EC 1935/2004, USP class VI & NSF and can be sterilised by autoclaving, gamma irradiation or Ethylene Oxide.

CONTACT

Paul Dale
Verder Ltd
paul.dale@verder.co.uk
www.verderflex.com
+44 (0) 1924 221020

Thursday 13 June 2013 / file under Pharmaceuticals